Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Patterns Among Patients with Chronic or Small Lymphocytic Leukemia (CLL/SLL) in US Community Oncology Practices

被引：0

作者：

Hou, Jing-Zhou ^{[1
,2
]}

Blanc, Simon ^{[3
]}

Maglinte, Gregory A. ^{[4
]}

Vasudevan, Anupama ^{[3
]}

Rui, Anna ^{[3
]}

Gart, Michael ^{[5
]}

Hoa Pham ^{[4
]}

Aton, Lindsay ^{[3
]}

Wang, Brandon ^{[3
]}

Choksi, Rushir ^{[6
]}

机构：

[1] UPMC Hillman Canc Ctr, Lemieux Ctr Blood Canc, Hematol & BMT, Pittsburgh, PA USA

[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[3] Integra Connect PrecisionQ, W Palm Beach, FL USA

[4] BeiGene USA Inc, San Mateo, CA USA

[5] Integra Connect, W Palm Beach, FL USA

[6] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174915

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Fixed-duration orelabrutinib plus bendamustine and rituximab versus continuous Bruton Tyrosine Kinase inhibitor (BTKi) in treatment-naive chronic/small lymphocytic leukemia (CLL/SLL): A multicenter, nonrandomized, pragmatic clinical trial [J].

Cao, L-L. ;

Ding, K-Y. ;

Song, H. ;

Wang, C-C. ;

Xu, Q. ;

Zhou, C-Y. ;

Hu, M-G. ;

Ming, J. ;

Wu, G-L. ;

Fan, D-D. ;

Feng, Y-Y. ;

Wang, X-C. .

ANNALS OF ONCOLOGY, 2024, 35 :S612-S612

[32] Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study [J].

Maruyama, Dai ;

Wang, Chaochen ;

Tanizawa, Yoshinori ;

Cai, Zhihong ;

Huang, Yujing ;

Tajimi, Masaomi ;

Kusumoto, Shigeru .

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2023, 63 (04) :219-229

[33] Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia [J].

Mulligan, Stephen P. ;

Thompson, Philip A. ;

Wight, Joel ;

Anderson, Mary Ann ;

Handunnetti, Sasanka M. ;

Puig, Andrea ;

Su, Steve Y. S. ;

Naylor, Matthew J. .

LEUKEMIA & LYMPHOMA, 2025,

[34] Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry [J].

Mato, Anthony R. ;

Barrientos, Jacqueline C. ;

Sharman, Jeff P. ;

Brander, Danielle M. ;

Gutierrez, Meghan ;

Kadish, Karen ;

Arango-Hisijara, Israel ;

Upasani, Sandhya ;

Han, Jennifer ;

Huang, Qing ;

Iyengar, Reethi ;

Ghosh, Nilanjan .

BLOOD, 2020, 136

[35] Real-World Clinical Outcomes in Patients Initiating Covalent Btki (cBTKi) with and without Incident Cardiovascular Adverse Events By Line of Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) [J].

Dingli, David ;

De Nigris, Enrico ;

Leng, Siyang ;

Farooqui, Mohammed Z. H. ;

Yapici, Halit O. ;

Weimer, Ian ;

Jiao, Weiqi ;

Hyatt, Hayden W. ;

Zhang, Xuan ;

Lodaya, Kunal ;

Obeng-Kusi, Mavis .

BLOOD, 2024, 144 :3722-3723

[36] Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia [J].

Heyman, Benjamin ;

Choi, Michael ;

Kipps, Thomas J. .

EJHAEM, 2025, 6 (04)

[37] A Single Center Real World Study of Outcome and Resistance of Bruton Tyrosine Kinase Inhibitors (BTKi) in Chinese Patients with Chronic Lymphocytic Leukeima/Small Lymphocytic Lymphoma [J].

Zhu, Huayuan ;

Dai, Luomengjia ;

Sha, Yeqin ;

Lu, Xiao ;

Qian, Siqi ;

Qiu, Tonglu ;

Miao, Yi ;

Xia, Yi ;

Qin, Shuchao ;

Zhou, Ziyuan ;

Wu, Wei ;

Fan, Lei ;

Xu, Wei ;

Li, Jianyong .

BLOOD, 2023, 142

[38] The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia [J].

Brown, Jennifer R. ;

Barrientos, Jacqueline C. ;

Barr, Paul M. ;

Flinn, Ian W. ;

Burger, Jan A. ;

Anh Tran ;

Clow, Fong ;

James, Danelle F. ;

Graef, Thorsten ;

Friedberg, Jonathan W. ;

Rai, Kanti ;

O'Brien, Susan .

BLOOD, 2015, 125 (19) :2915-2922

[39] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL) [J].

Feinberg, Bruce ;

Schenkel, Brad ;

McBride, Ali ;

Ellis, Lorie ;

Radtchenko, Janna .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 :S204-S205

[40] REAL-WORLD EFFECTIVENESS AND TREATMENT PATTERNS OF VENETOCLAX-BASED REGIMENS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN COMMUNITY SETTINGS [J].

Zakeri, M. ;

Emechebe, N. ;

Chowdhery, R. ;

Jawaid, D. ;

Alhasani, H. ;

Manzoor, B. S. .

VALUE IN HEALTH, 2023, 26 (06) :S54-S55

← 1 2 3 4 5 →